HB 2033 would create a new chapter in Washington law governing the taxation of nicotine products. The bill defines a broad set of tobacco and nicotine-related terms, including cigars, cigarettes, moist snuff, chewing tobacco, and other products containing tobacco or nicotine, whether derived from tobacco or created synthetically, so long as they are intended for human consumption or oral/nasal use. It also defines the business categories involved in the nicotine supply chain, such as manufacturers, distributors, retailers, and affiliated and unaffiliated entities, and establishes rules for determining the taxable sales price in different transaction structures.
The measure appears designed to provide a comprehensive framework for taxing nicotine products and to clarify how the tax applies across different types of sales and business relationships. It includes authority for the Department of Revenue to adopt rules on determining taxable sales price. The bill also contains a contingent effective-date provision stating that it takes effect January 1, but becomes null and void if specific funding is not provided by June 30 in the omnibus appropriations act.
Impact
HB 2033 would amend Washington’s tobacco tax statutes by expanding and clarifying the definitions and tax treatment of nicotine products, including synthetic nicotine and other non-cigarette tobacco products. It would affect manufacturers, distributors, retailers, and other businesses engaged in selling or distributing tobacco products in the state, and would likely change how taxable sales prices are calculated for affiliated and unaffiliated transactions. The bill also gives the Department of Revenue rulemaking authority to administer the tax provisions, and its implementation depends on funding in the state budget.
Sentiment
The available voting history suggests generally favorable but not unanimous support. The House Finance Committee approved the bill 10-5, and the House Appropriations Committee later approved a first substitute version 19-12. No committee transcript is available, so the record does not show detailed public debate, but the votes indicate the bill had majority support while still drawing meaningful opposition.
Contention
The main points of contention likely center on whether and how broadly Washington should tax nicotine products, especially products containing synthetic nicotine and other nontraditional tobacco alternatives. Another likely issue is the complexity of the taxable sales price rules, which distinguish among affiliated and unaffiliated manufacturers, distributors, retailers, and direct-to-consumer sales. The funding contingency may also have been a concern, since the bill would be void without specific appropriations language in the omnibus budget.